The forecast for stomach malignant neoplasms mortality among females in the U.S. is stable from 2024 to 2028, with a consistent rate of 2.6 per 100,000 women. As of 2023, the mortality rate stood at 2.6, indicating no change over the projected period. This static trend reflects a zero percent year-on-year variation and suggests no improvement in mortality reductions. The compound annual growth rate (CAGR) over these five years is also zero, reinforcing the trend of stability.
Future trends to watch for include advancements in early detection and treatment technologies, potential shifts in demographic health patterns, and changes in healthcare policies, all of which could influence mortality rates beyond the current forecast period.
